The Effects of the Yi Jin Jing on the Muscles and Bones of Adults

NCT07753291 | Recruiting

• 1 other identifier: 2025BL02-161-02
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Observation of the effects of Yi Jin Jing on the muscles and bones of adults

Conditions

The Condition of Adults' Muscles and Bones

Keywords

Yijinjing

Outcome Measures

Primary Outcomes (1)

• Appendicular Skeletal Muscle Index

  \*\*Appendicular Skeletal Muscle Index (ASMI)\*\* = appendicular lean mass (kg) / height² (m²). It reflects muscle mass, used for sarcopenia diagnosis. Lower values indicate muscle loss, linked to aging, malnutrition, or disease.

  Day 180 ± 10 days

Secondary Outcomes (5)

• Handgrip strength

  Day 180 ± 10 days

• Nutrition intake form（MNA）

  Day 180 ± 10 days

• Fried

  Day 180 ± 10 days

• FRAIL

  Day 180 ± 10 days

• SPPB

  Day 180 ± 10 days

Study Arms (1)

The effects of Yi Jin Jing on the muscles and bones of adults

EXPERIMENTAL

Yijinjing exercise

Behavioral: Yijinjing

Interventions

Yijinjing BEHAVIORAL

Yijinjing

The effects of Yi Jin Jing on the muscles and bones of adults

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \) Age 18-90 years inclusive; 2) Generally healthy, no acute or chronic diseases affecting major organ functions; 3) No cognitive impairment, able to understand and comply with study procedures; 4) Willing and able to provide written informed consent; 5) No pregnancy or lactation (for females); 6) No recent (within 3 months) major surgery, hospitalization, or significant weight change (\>5% body weight).

You may not qualify if:

• Presence of acute or unstable chronic diseases (e.g., uncontrolled hypertension, diabetes, heart failure, or malignancy);
• Severe cognitive impairment, psychiatric disorders, or inability to follow study instructions;
• Recent (≤3 months) major surgery, trauma, or hospitalization;
• Pregnancy, lactation, or childbearing potential without reliable contraception;
• Body mass index (BMI) \<16 or \>40 kg/m²;
• Current use of medications affecting muscle or nutritional metabolism (e.g., corticosteroids, anabolic steroids);
• Participation in another interventional trial within 30 days.

Sponsors & Collaborators

• Beijing Hospital of Traditional Chinese Medicine: lead

Study Sites (1)

No. 23, Ganju Road, Dongcheng District, Beijing

Beijing, China

RECRUITING

Central Study Contacts

jin he hejin

CONTACT

+8617600765734; 17600765734@163.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Investigator

Study Record Dates

• First Submitted: August 4, 2026
• First Posted: August 7, 2026
• Study Start: July 19, 2026
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2028
• Last Updated: August 7, 2026

Record last verified: 2026-08

Locations

CN (1)